674
Participants
Start Date
July 31, 2011
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
OPC-34712
Higher dose tablet, once daily, for six weeks,
OPC-34712
Middle dose tablet, once daily, for six weeks
OPC-34712
Lower dose tablet, once daily, for six weeks
Placebo
Placebo, once daily, for six weeks
Taipei
New Taipei City
Taoyuan District
Kaohsiung City
Manila
Makati City
Mandaluyong
Cebu City
Davano City
Zagreb
Zagreb
Buffalo
North Miami
North Miami
Memphis
Flowood
Taichung
Rijeka
St Louis
Monterrey
Monterrey
Overland Park
Lake Charles
Shreveport
Little Rock
Springdale
Dallas
Houston
San Luis Potosí City
Austin
Bratislava
Pico Rivera
Long Beach
Escondido
San Diego
Orange
Bojnice
Rimavská Sobota
Moscow
Moscow
Moscow Region
Arkhangelsk
Petrozavodsk
Village Nikolskoe
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saratov
Samara
Nizhny Novgorod
Tomsk
Bogotá
Medellín
Pereira
Col. Florida
Mexico City
Michalovace
Rožňava
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY